ARBs vs ACEis for hypertension: Is one better than the other?
There are no significant differences between ARBs* and ACE** inhibitors in long-term prevention of cardiovascular (CV) outcomes among people initiating the antihypertensive drugs as monotherapy, but the former comes with fewer side effects than the latter, reveals a large, head-to-head, real-world comparative study.
